Royal Bank of Canada »

Amphastar Pharmaceuticals In shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Amphastar Pharmaceuticals In shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Amphastar Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Amphastar Pharmaceuticals In held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amphastar Pharmaceuticals In by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.9M 2.1M 0.91

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding Amphastar Pharmaceuticals In

Linden Advisors
Wellesley Investment Advisors
Camden Asset Management
Oaktree Capital Management
Tenor Capital Management
Empyrean Capital Partners
MacKay Shields
Silverback Asset Management
Calamos Advisors
Morgan Stanley
Leucadia National Corporation
Russell Investments
FMR
BlackRock
Advent Capital Management

View all funds holding Amphastar Pharmaceuticals In